Literature DB >> 21985291

Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract.

François Audenet1, Olivier Traxer, David R Yates, Olivier Cussenot, Morgan Rouprêt.   

Abstract

OBJECTIVES: •  To discuss how the development of new generation flexible ureterorenoscopes in combination with photodynamic diagnosis (PDD) improves the assessment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). •  Ultimately, this may allow accurate tumour classification and the ability to select which patients would benefit from conservative treatment as opposed to radical surgery.
MATERIALS AND METHODS: •  We conducted an exhaustive Pubmed literature search using a combination of keywords including: ureterorenoscopy, UUT-UCC diagnosis, PDD, narrow band imaging, conservative treatment UUT-UCC and molecular urinalysis. •  We then selected salient high calibre articles relevant to our objective.
RESULTS: •  We give specific consideration to anatomical aspects of UUT-UCC investigation, PDD in UCC, aminolevulinic acid and its derivatives, autofluorescence, narrow band imaging, molecular marker analysis and the recent advances in ureterorenoscopic technology. •  The traditional pitfalls of UUT-UCC diagnosis, namely poor visualisation and difficulty in obtaining representative histological samples, are being circumvented by the introduction of modern digital flexible ureteroscopes that can be combined with PDD and molecular analysis to improve tumour classification, deferring to conservative treatment accordingly.
CONCLUSION: •  The accuracy of the diagnostic work-up of UUT-UCC is improving due to advances in technology, pharmaceutical agents and incorporation of molecular markers, all factors allowing us to characterise tumours of the UUT more definitively.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21985291     DOI: 10.1111/j.1464-410X.2011.10363.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  10 in total

Review 1.  Flexible ureterorenoscopic management of upper tract pathologies.

Authors:  Athanasios Papatsoris; Kemal Sarica
Journal:  Urol Res       Date:  2012-09-13

Review 2.  Risk-adapted strategy for the kidney-sparing management of upper tract tumours.

Authors:  Thomas Seisen; Pierre Colin; Morgan Rouprêt
Journal:  Nat Rev Urol       Date:  2015-02-24       Impact factor: 14.432

3.  The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database.

Authors:  Laurent Nison; Morgan Rouprêt; Grégory Bozzini; Adil Ouzzane; François Audenet; Géraldine Pignot; Alain Ruffion; Jean-Nicolas Cornu; Sophie Hurel; Antoine Valeri; Mathieu Roumiguie; Thomas Polguer; Nicolas Hoarau; Olivier Mérigot de Treigny; Evanguelos Xylinas; Alexandre Matte; Stéphane Droupy; Pierre Olivier Fais; Aurélien Descazeaud; Pierre Colin
Journal:  World J Urol       Date:  2012-10-16       Impact factor: 4.226

Review 4.  Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes.

Authors:  François Audenet; Olivier Traxer; Karim Bensalah; Morgan Rouprêt
Journal:  World J Urol       Date:  2012-09-25       Impact factor: 4.226

5.  Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancers.

Authors:  Angela Gillan; Ismail El-Mokadem; Bhavan Rai; Stephen Lang; Jason Alcorn; Altaf Shams Ud Din; Ranan Dasgupta; Chandra Shekhar Biyani; Ghulam Nabi
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

Review 6.  Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma.

Authors:  Zine-Eddine Khene; Romain Mathieu; Solène-Florence Kammerer-Jacquet; Thomas Seisen; Morgan Roupret; Shahrokh F Shariat; Benoit Peyronnet; Karim Bensalah
Journal:  Transl Androl Urol       Date:  2016-10

7.  Evaluation of the Spies TM modalities image quality.

Authors:  Esteban Emiliani; Michele Talso; Mohammed Baghdadi; Aaron Barreiro; Andrea Orosa; Pol Serviàn; Pavel Gavrilov; Silvia Proietti; Olivier Traxer
Journal:  Int Braz J Urol       Date:  2017 May-Jun       Impact factor: 1.541

Review 8.  Risk stratification for upper tract urinary carcinoma.

Authors:  Daniel Benamran; Thomas Seisen; Elias Naoum; Christophe Vaessen; Jérome Parra; Pierre Mozer; Shahrokh F Shariat; Morgan Rouprêt
Journal:  Transl Androl Urol       Date:  2020-08

9.  Prognostic significance of inflammation-based prognostic scoring in patients with upper urinary tract urothelial carcinoma.

Authors:  Taisuke Suyama; Shigeki Kanbe; Masanobu Maegawa; Hirofumi Shimizu; Koichi Nakajima
Journal:  Int Braz J Urol       Date:  2019 May-Jun       Impact factor: 1.541

10.  Accuracy of photodynamic diagnosis in the detection and follow-up of patients with upper urinary tract lesions: Initial 3-year experience.

Authors:  Omar M Aboumarzouk; Sarfraz Ahmad; Harry Moseley; Slawomir G Kata
Journal:  Arab J Urol       Date:  2012-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.